Related Experiment Video
Updated: Jun 26, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Oxidative DNA damage in retinopathy of prematurity
1Department of Ophthalmology Medical Faculty, Ataturk University, Erzurum, Turkey. orhanates@atauni.edu.tr
Insights
Oxidative damage markers, 8-hydroxy 2-deoxyguanosine (8-OHdG) and malondialdehyde (MDA), are elevated in premature infants with retinopathy of prematurity (ROP). These biomarkers show potential for ROP screening in high-risk infants.
Area of Science:
- Biochemistry
- Neonatology
- Ophthalmology
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Oxidative stress is implicated in the pathogenesis of ROP, but specific biomarkers require validation.
Purpose of the Study:
- To investigate levels of oxidative damage markers, specifically 8-hydroxy 2-deoxyguanosine (8-OHdG) and malondialdehyde (MDA), in premature infants with and without ROP.
Main Methods:
- Fifty premature infants (birthweight <1500g or gestational age <32 weeks) were recruited and divided into ROP (n=25) and no-ROP (n=25) groups.
- Blood and urine samples were analyzed for 8-OHdG and MDA levels at 4-6 postnatal weeks.
Main Results:
- Significantly higher leukocyte and urine 8-OHdG levels were found in infants with ROP compared to controls (p<0.001).
- Plasma and urine MDA levels were also significantly elevated in the ROP group (p<0.001).
- Strong correlations were observed between 8-OHdG and MDA levels.
Conclusions:
- Leukocyte DNA 8-OHdG and urine 8-OHdG levels are potential biomarkers for ROP screening in premature infants.
- Elevated oxidative damage markers may indicate increased risk or presence of ROP.
Purpose:
This study examines the levels of oxidative damage in patients with retinopathy of prematurity (ROP).
Methods:
Fifty patients were recruited with a birthweight below 1500 g or gestational age below 32 weeks. The cases were classified into those who developed ROP (n=25) and those without ROP (n=25). The authors obtained blood and urine samples from each infant, for measuring 8-hydroxy 2-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) levels, at the time of the first examination at 4-6 postnatal weeks.
Results:
A significant difference was observed in leukocyte and urine 8-OHdG levels in patients with ROP compared to those without ROP (p<0.001 for both). Similarly, a significant difference was observed in plasma and urine MDA levels in patients with ROP compared to those without ROP (p<0.001 for both). In addition, significant correlations were found between levels of 8-OHdG in leukocyte DNA and plasma MDA (r=0.859, p<0.001), and between levels of urine 8-OHdG excretion and urine MDA (r=0.563, p<0.001).
Conclusions:
8-OHdG in leukocyte DNA and urine levels in premature infants can be useful as an indicator for ROP screening.
Related Concept Videos
Diabetic Retinopathy
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

